Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$14.66 USD
+0.16 (1.10%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $14.67 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$14.66 USD
+0.16 (1.10%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $14.67 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
Why Elanco Animal Health Incorporated (ELAN) Might be Well Poised for a Surge
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 33.33% and 8.48%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q4 Earnings Expected to Decline
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Elanco Animal Health Incorporated (ELAN) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 350.00% and 5.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Elanco (ELAN) Ahead of Earnings?
by Zacks Equity Research
Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bayer Initiates a Phase III Study in Heart Failure Patients
by Zacks Equity Research
Bayer (BAYRY) initiates a phase III study to evaluate finerenone compared to placebo in more than 5,500 symptomatic heart failure patients with a left ventricular ejection fraction.
Bayer (BAYRY) Submits Applications for Heart Failure Drug
by Zacks Equity Research
Bayer (BAYRY) seeks approval of chronic heart failure drug, vericiguat, in the EU and Japan.
Elanco Animal Health Incorporated (ELAN) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of -45.83% and -9.94%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Elanco (ELAN) This Earnings Season?
by Zacks Equity Research
Elanco (ELAN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bayer (BAYRY) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Bayer (BAYRY) beats earnings estimates for the first quarter of 2019.
Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Bayer (BAYRY) beats earnings estimates in the fourth quarter of 2019.
New Strong Sell Stocks for February 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Elanco (ELAN) Surges: Stock Moves 5.3% Higher
by Zacks Equity Research
Elanco (ELAN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
New Strong Sell Stocks for January 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Zoetis Surges 45.3% YTD on Strong Portfolio & New Approvals
by Zacks Equity Research
Zoetis (ZTS) surges on strong performance year to date, backed by a solid portfolio and prudent acquisitions.
Zoetis (ZTS) Acquires ZNLabs to Bolster Diagnostics Portfolio
by Zacks Equity Research
Zoetis (ZTS) acquires ZNLabs and expands its reference laboratory capabilities in the United States.
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 15.38% and 1.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More
by Zacks Equity Research
Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q3 Earnings Expected to Decline
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zoetis Appoints Kristin Peck as New CEO, Alaix to Retire
by Zacks Equity Research
Zoetis (ZTS) names executive vice president Kristin Peck as the new CEO, effective Jan 1, 2020.
Zoetis (ZTS) Receives EC Approval for Simparica Trio in Dogs
by Zacks Equity Research
Zoetis' (ZTS) leading animal health portfolio gets a boost with the approval of Simparica Trio.
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco
by Zacks Equity Research
Bayer (BAYRY) inks deal with Elanco to divest its animal health business for $7.6 billion.